JYANT TECH INC has a total of 19 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 2011. It filed its patents most often in China, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, basic materials chemistry and biotechnology are AUREOGEN BIOSCIENCES INC, OSAKA BIOSCIENCE INST and ST GEORGES HOSPITAL MEDICAL SCHOOL.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 7 | |
#2 | United States | 6 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Hong Kong | 1 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Basic materials chemistry | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Lillard James W | 11 |
#2 | Singh Rajesh | 8 |
#3 | Lillard Jr James W | 6 |
#4 | Singh Shailesh | 5 |
#5 | Stiles Jonathan | 2 |
#6 | Lillard James W W | 1 |
#7 | Singh Udai | 1 |
Publication | Filing date | Title |
---|---|---|
CN109310083A | Nanometer formulation for plant | |
EP3253797A1 | Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof | |
US2016115214A1 | Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof | |
EP2652508A2 | The use of anti-cxcl13 and anti-cxcr5 antibodies for the treatment or detection of cancer |